What We're Reading: Page 236
Industry reads hand-picked by our editors
Nov 20, 2018
-
The Wall Street Journal
Novartis CEO Bets on Cutting-Edge Science to Remake Drug Giant
-
Forbes
Is Amarin's Fish-Oil-Derived Drug A Historic Breakthrough Or Not? It's Complicated
-
Reuters
Big pharma leaves big gaps: drugmakers urged to do more for poor
-
Axios
PhRMA spread money far and wide in Trump's first year
Nov 19, 2018
Nov 16, 2018
Nov 15, 2018
-
Reuters
Pfizer loses drug patent fight in UK top court, may face claims
-
The New York Times
U.S. companies are fighting their big pharma addiction
-
The Wall Street Journal
To curb wasteful health spending, Walmart to send employees traveling for spine surgery
Nov 14, 2018
-
Stat
Extraordinary tactics, perverse incentives: Makers of top-selling drugs hike prices in lockstep, and patients bear the cost
-
Bloomberg
SoftBank-backed biotech Roivant climbs to $7 billion valuation
-
CNBC
Tweet leads Mark Cuban to invest in biotech company Perlara and quest to cure rare genetic disease
-
The New York Times
20 Americans die each day waiting for organs. Can pigs save them?
Nov 13, 2018
Nov 12, 2018
-
Los Angeles Times
With better drugs for high cholesterol, doctors become more ambitious with their treatment goals
-
Chemical & Engineering News
Have antisense oligonucleotides hit their stride?
-
The New York Times
Dementia is getting some very public faces
-
CNBC
The inside story of Quanttus, a failed health tech start-up whose alums are now health leaders at Apple, Amazon, Alphabet and other giants
Previous
